DIA 2025 Global Annual Meeting

Component Type: Session
Level: Intermediate

Addressing data gaps in drug development, especially capturing patient experiences in both rare and non-rare diseases, is crucial. From Proof of Concept to Proof of Value, integrated evidence planning and incorporating patient voices in Target Product Profile (TPP) creation drive comprehensive evidence generation.

Learning Objectives

Insight into company approach for building an integrated evidence framework; Discuss the utility in global drug development context, including post-marketing efforts; Insight into strategies to create a patient informed comprehensive Target Product Profile; Strategies outlined in the interactive guide to align PAG and industry efforts in creating a comprehensive Target Product Profile.

Chair

Agathe Le Lay, PhD, MSc

Speaker

What Are We Missing? Potential Data Gaps in Rare Disease Drug Development and the Importance of Capturing Lived Experience
Gina Calarco, BSN, MPH

New Strategies and Practices to Incorporate the Patient Voice in Target Product Profile Creation
Patricia Davidson, MPA